Tumor cavitation is associated with epidermal growth factor expression and is a predictor of poor outcome in patients with stage I non-small cell lung cancer

被引：0
|
作者：
Onn, A [1 ]
Marom, E [1 ]
Isobe, T [1 ]
Choe, DH [1 ]
Correa, AM [1 ]
Putnam, JB [1 ]
Herbst, RS [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
CHEST | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1378/chest.124.4_MeetingAbstracts.102S-a
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：102S / 102S
页数：1
相关论文
共 50 条
  • [41] Reduced expression of claudin-7 is associated with poor outcome in non-small cell lung cancer
    Yamamoto, Taketsugu
    Oshima, Takashi
    Yoshihara, Kazue
    Yamanaka, Sumitaka
    Nishii, Teppei
    Arai, Hiromasa
    Inui, Kenji
    Kaneko, Takeshi
    Nozawa, Akinori
    Woo, Tetsukan
    Rino, Yasushi
    Masuda, Munetaka
    Imada, Toshio
    ONCOLOGY LETTERS, 2010, 1 (03) : 501 - 505
  • [42] Tumor cellular proliferation is associated with enhanced immune checkpoint expression in stage I non-small cell lung cancer
    Mitchell, Kyle G.
    Parra, Edwin R.
    Nelson, David B.
    Zhang, Jiexin
    Wistuba, Ignacio I.
    Fujimoto, Junya
    Roth, Jack A.
    Antonoff, Mara B.
    Corsini, Erin M.
    Vaporciyan, Ara A.
    Hofstetter, Wayne L.
    Mehran, Reza J.
    Swisher, Stephen G.
    Rice, David C.
    Sepesi, Boris
    Walsh, Garrett L.
    Behrens, Carmen
    Kalhor, Neda
    Weissferdt, Annikka
    Moran, Cesar A.
    Lee, J. Jack
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2019, 158 (03): : 911 - +
  • [43] Analysis of tumor abnormal protein expression and epidermal growth factor receptor mutation status in non-small cell lung cancer
    Cheng, Yuanjun
    Chen, Bin
    Fang, Qianru
    Zang, Guohui
    Yao, Jie
    DISCOVER ONCOLOGY, 2024, 15 (01)
  • [44] Epidermal growth factor receptor expression, signal pathway, and inhibitors in non-small cell lung cancer
    Bunn, PA
    Franklin, W
    SEMINARS IN ONCOLOGY, 2002, 29 (05) : 38 - 44
  • [45] CHANGES IN EPIDERMAL GROWTH FACTOR RECEPTOR EXPRESSION DURING CHEMOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Jakobsen, Jan N.
    Santoni-Rugiu, Eric
    Sorensen, Jens B.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1082 - S1082
  • [46] Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer
    Jan Nyrop Jakobsen
    Eric Santoni-Rugiu
    Jens Benn Sørensen
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 131 - 137
  • [47] Changes in epidermal growth factor receptor expression during chemotherapy in non-small cell lung cancer
    Jakobsen, Jan Nyrop
    Santoni-Rugiu, Eric
    Sorensen, Jens Benn
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (01) : 131 - 137
  • [48] Elevated expression of DTYMK is associated with poor prognosis in patients with Non-small cell lung cancer
    Wang, Wei
    Guo, Zhi-Hua
    Lu, Xin-Peng
    Liao, Dong-Jiang
    Peng, Gui-Lin
    Xu, Xin
    Yin, Wei-Qiang
    He, Jian-Xing
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 22027 - 22033
  • [49] Prognosis of Patients with Stage I Non-Small Cell Lung Cancer
    Flores, C. J.
    Chirinos, L.
    Enriquez, D.
    Schwarz, L. J.
    Mas, L.
    Rojas, V.
    Aguilar, A.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (11) : S1185 - S1185
  • [50] MCAM expression is associated with poor prognosis in non-small cell lung cancer
    Zhang, X.
    Wang, Z.
    Kang, Y.
    Li, X.
    Ma, X.
    Ma, L.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2014, 16 (02): : 178 - 183
12345